Doxycycline add-on therapy for lung improvement in tuberculosis
Treatments studied
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 21 years old or older
- Have confirmed active pulmonary TB, with positive test results (smear, NAAT, or culture)
- Start TB treatment within the past 14 days, or be about to start standard TB treatment
- Chest X-ray must show lung involvement with one or more cavities
- Be able to sign informed consent
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This trial tests whether the antibiotic doxycycline can prevent lung scarring (fibrosis) after a serious TB infection. You may be eligible if you are currently being treated for active TB and have significant lung damage on your chest X-ray.
This trial tests whether adding the antibiotic doxycycline to standard treatment can improve recovery in patients with tuberculosis of the brain (TB meningitis). It may help reduce brain swelling and damage.
This trial tests whether adding doxofylline to your usual inhalers can improve lung function and breathing tests in people with stable COPD. It may help if your COPD is moderate to worse and you have been stable for at least 6 months.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.